Celgene Corp (CELG)

CELG (NASDAQ:Drugs)
$88.54
pos +1.88
+2.17%
Today's Range: 87.80 - 88.87 | CELG Avg Daily Volume: 5,179,700
Last Update: 07/23/14 - 9:41 AM EDT
Volume: 435,066
YTD Performance: 2.57%
Open: $88.50
Previous Close: $86.66
52 Week Range: $65.76 - $90.50
Oustanding Shares: 800,833,654
Market Cap: 68,911,735,927
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 17 18 19 19
Moderate Buy 1 1 1 2
Hold 4 4 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.41 1.39 1.30 1.33
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 54.34
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
54.34 54.70 28.87
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
18.19% 25.52% 183.29%
GROWTH 12 Mo 3 Yr CAGR
Revenue 17.90 0.79 0.21
Net Income -0.40 0.65 0.18
EPS 2.00 0.84 0.22
Earnings for CELG:
EBITDA 2.35B
Revenue 6.49B
Average Earnings Estimates
Qtr (06/14) Qtr (09/14) FY (12/14) FY (12/15)
Average Estimate $0.77 $0.82 $3.18 $4.40
Number of Analysts 3 3 3 3
High Estimate $0.79 $0.85 $3.27 $4.93
Low Estimate $0.73 $0.80 $3.12 $4.09
Prior Year $0.70 $0.69 $2.68 $3.18
Growth Rate (Year over Year) 9.52% 17.99% 18.78% 38.32%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
If you're worried about these moves, it's time to cash out.

Take a Yellen Opportunity Real Money Pro($)

There's a great entry point in Celgene at $84.
If you don't like speculation, just hike the margin requirement.
The lower risk stocks have been providing consistent returns.
Be bitter about the soccer match, not the latecomers and the naysayers. 
Another quarter, another run to record highs.
Become more aggressive about the real valuations of companies.
Shorts take much more homework than longs.
Update
Jun 04, 2014 | 7:00 AM EDT
Jefferies Global Healthcare Conference (Day 3 of 4) - 06/02/14 - 06/05/14 New York, NY
Bearish
May 29, 2014 | 7:46 AM EDT
CELG was downgraded from Overweight to Neutral, JP Morgan said. Valuaiton call, based on a $170 price target. 

Columnist Conversations

Kass:
Coming up on my Diary why I have moved from a neutral to more bullish position on Citigroup. With a lot of he...
Heavy trading in Microsoft August calls. The stock opened higher after the company's EPS number missed estimat...
This morning we are seeing PBYI up 270% to 218 on Phase 3 results for their breast cancer drug neratnib. Price...
Markets seem to be taking breaking news going across wire that two Ukrainian militaryfighter jets have been sh...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.